Today: 7 February 2026
Subscribe
Browse Category

Market Outlook News 20 December 2025 - 21 December 2025

US Stock Market Week Ahead: Santa Rally Window, Q3 GDP Catch‑Up Data, and Fed Rate Bets Put Wall Street on Watch (Dec. 22–26, 2025)

US Stock Market Week Ahead: Santa Rally Window, Q3 GDP Catch‑Up Data, and Fed Rate Bets Put Wall Street on Watch (Dec. 22–26, 2025)

Wall Street heads into Christmas week with a familiar year-end setup—strong full‑year gains, a choppy December, and a market that can swing sharply when trading desks are half-staffed. Stocks finished the last full trading week of 2025 with a late rebound powered by a renewed bid for AI-linked names. On Friday, Dec. 19, the S&P 500 rose 0.88% to 6,834.50, the Nasdaq Composite gained 1.31% to 23,307.62, and the Dow added 0.38% to 48,134.89. Reuters+1 The bigger story: investors are about to get a burst of long-delayed U.S. economic data—starting with a first look at third‑quarter GDP—at the same time the
21 December 2025
····
Unilever PLC Stock (UL, ULVR) Outlook on Dec. 21, 2025: Post-Magnum Spin-Off Catalysts, Analyst Targets, and What Investors Are Watching

Unilever PLC Stock (UL, ULVR) Outlook on Dec. 21, 2025: Post-Magnum Spin-Off Catalysts, Analyst Targets, and What Investors Are Watching

Unilever PLC stock has entered a “new era” of sorts as 2025 closes out. The consumer staples giant—known for brands like Dove, Vaseline, Hellmann’s, Domestos, and Axe—has just completed one of its biggest structural moves in years: the demerger of its ice cream business into The Magnum Ice Cream Company (home to Magnum, Ben & Jerry’s, Wall’s/Cornetto), paired with an 8-for-9 share consolidation designed to keep per-share metrics comparable. Reuters+2Unilever+2 As of Sunday, December 21, 2025, markets are closed in most major venues, but the newsflow around Unilever shares (and the logic investors are using to value them) is very
21 December 2025
······
UK Stock Market Today (21 December 2025): FTSE 100 Near 10,000 as BoE Rate Cut Reframes the Outlook for 2026

UK Stock Market Today (21 December 2025): FTSE 100 Near 10,000 as BoE Rate Cut Reframes the Outlook for 2026

The UK stock market is closed today (Sunday, 21 December 2025), but investors are heading into the Christmas-shortened trading week with the FTSE 100 firmly in “near-10,000” territory, a fresh Bank of England rate cut, and a growing debate about whether 2026 marks the year the UK’s long-running valuation discount finally starts to close. Friday’s cash-market finish left London equities on a strong footing: the FTSE 100 ended at 9,897.42 (+0.61%), while the more domestically sensitive FTSE 250 closed at 22,312.71 (-0.06%) on Hargreaves Lansdown’s delayed pricing. Hargreaves Lansdown+1 With the market shut for the weekend, attention shifts to futures
21 December 2025
·····
Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

December 21, 2025 — Meesho Limited’s stock has become the headline-grabber of India’s late-2025 IPO wave, delivering a blistering post-listing run that’s sparked equal parts excitement and unease on Dalal Street. After debuting on December 10, 2025, Meesho’s shares surged rapidly—at one point gaining more than 100% over the IPO price—and the move has been amplified by a rare cocktail of bullish brokerage initiations, thin tradeable supply, and settlement mechanics that have punished short sellers. Reuters+2LiveMint+2 Below is what’s driving Meesho Limited stock right now, where analysts see it heading, and what investors are watching as the dust settles after
21 December 2025
····
Singapore Stock Market Today: STI Holds Near 4,570 as Banks, S-REIT Flows and Year-End Positioning Shape SGX Outlook (Dec 21, 2025)

Singapore Stock Market Today: STI Holds Near 4,570 as Banks, S-REIT Flows and Year-End Positioning Shape SGX Outlook (Dec 21, 2025)

SINGAPORE — The Singapore Exchange (SGX) is closed today (Sunday, Dec 21), leaving investors to digest a tight, range-bound finish to last week and prepare for the final trading stretch of 2025. The Straits Times Index (STI) ended Friday (Dec 19) essentially flat, slipping 0.02% to 4,569.78, signalling consolidation after a strong run this year and into a holiday period where liquidity typically thins out and stock-specific moves can dominate. The Straits Times Singapore stocks: what happened at the last close Friday’s session was a microcosm of how Singapore stocks have been trading lately: steady at the index level, but
21 December 2025
····
DBS Group Holdings Ltd Stock (SGX: D05) Outlook on Dec 21, 2025: Record Highs, Big Dividends, and the 2026 Margin Test

DBS Group Holdings Ltd Stock (SGX: D05) Outlook on Dec 21, 2025: Record Highs, Big Dividends, and the 2026 Margin Test

SINGAPORE — December 21, 2025 — DBS Group Holdings Ltd (SGX: D05, Reuters: DBSM.SI) ends the week near record territory after touching S$56.00 earlier in December and closing S$54.87 on Friday, Dec 19. The stock is up about +25.5% year-to-date and has become the centre of gravity for Singapore’s “income + quality” investing narrative: high payouts, active capital returns, and a franchise still gaining traction in wealth and transaction banking—even as investors brace for lower interest rates and softer net interest margins in 2026. MarketScreener+2TradingView+2 What’s moving DBS Group stock right now is the collision of three forces: Below is
21 December 2025
·····
CSL Limited Stock (ASX: CSL) Outlook on 21 December 2025: Seqirus Spin-Off Delay, Buyback Momentum, and Analyst Price Targets

CSL Limited Stock (ASX: CSL) Outlook on 21 December 2025: Seqirus Spin-Off Delay, Buyback Momentum, and Analyst Price Targets

CSL Limited (ASX: CSL) heads into the final stretch of 2025 with its share price still under pressure—but with a growing stack of “things that matter” piling up beneath the surface: a sizeable on‑market buyback steadily absorbing stock, a major US manufacturing investment designed to reinforce its plasma-therapy moat, and a high-profile strategic reset that’s trying to simplify a complex, three‑engine biotech into something the market can price with less guesswork. As of the most recent trading day (Friday, 19 December 2025), CSL shares closed at A$175.08, after a volatile month that saw the stock slide from the mid‑A$180s toward
21 December 2025
·····
Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements, renewed focus on insurance premiums, and a fresh run of deal and IPO headlines that are reshaping investor expectations for 2026. Reuters+3Reuters+3Reuters+3 Below is a comprehensive roundup of the most market-moving healthcare news, plus the latest forecasts and sector analysis shaping how investors are positioning across pharma, biotech, managed care, medtech, and healthcare services into 2026. 1) Drug pricing is
20 December 2025
············
Semiconductor Stocks News (Dec. 20, 2025): Micron’s AI Memory Boom, Nvidia “Cheap” Valuation Calls, and the 2026 Outlook

Semiconductor Stocks News (Dec. 20, 2025): Micron’s AI Memory Boom, Nvidia “Cheap” Valuation Calls, and the 2026 Outlook

December 20, 2025 — Semiconductor stocks are heading into the final stretch of 2025 with a familiar mix of powerful tailwinds and stubborn risks. On one side: accelerating AI infrastructure demand, a tightening memory market, and a renewed capex cycle that’s lifting chipmaking equipment makers. On the other: widening U.S.–China policy uncertainty, supply constraints in the most in-demand components (especially HBM and advanced packaging), and an uneven recovery across the “non-AI” parts of the chip universe. Below is the full picture of the latest news, forecasts, and analyst takes as of Dec. 20, 2025, plus what investors are watching next.
20 December 2025
······
Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research Corporation (NASDAQ: LRCX) is ending the week on a sharp upswing after a volatile December stretch—and the latest headlines on December 20, 2025 point to a clear driver: a cluster of analyst upgrades and price-target hikes tied to strengthening AI- and memory-led semiconductor spending expectations. With U.S. markets closed on Saturday, the most recent tape investors are working from is Friday, Dec. 19, when Lam Research stock closed at $172.27 (+4.60%), after trading as high as $173.58 on unusually heavy volume. Investing.com+1 Below is a comprehensive roundup of the current news, forecasts, and analyses circulating on 20.12.2025, plus
20 December 2025
·····
Tokyo Stock Exchange Update (Dec. 20, 2025): BOJ Rate Hike, Yen Volatility, New ETFs, and the 2026 Outlook

Tokyo Stock Exchange Update (Dec. 20, 2025): BOJ Rate Hike, Yen Volatility, New ETFs, and the 2026 Outlook

Tokyo Stock Exchange (TSE) investors head into the weekend with a familiar Japanese-market paradox: the Bank of Japan (BOJ) has pushed rates to a three-decade high, yet the yen is still weakening—forcing portfolio managers to rethink what “tightening” actually means for Japanese equities going into year-end and early 2026. Reuters+1 With Tokyo markets closed on Saturday, December 20, 2025, the story is less about today’s tape and more about how Friday’s policy signals, currency swings, and exchange-level rule enforcement are setting up the next act on the Tokyo Stock Exchange—across blue-chip exporters, banks, small caps, ETFs, and the steadily intensifying
20 December 2025
·····
CoreWeave (CRWV) Stock Surges on Citi Buy Call and DOE Genesis Mission: Latest News, Analyst Targets, and 2026 Outlook

CoreWeave (CRWV) Stock Surges on Citi Buy Call and DOE Genesis Mission: Latest News, Analyst Targets, and 2026 Outlook

December 20, 2025 — CoreWeave, Inc. (Nasdaq: CRWV) is back in the spotlight after a sharp rally in the latest U.S. trading session. The AI cloud specialist’s shares last traded around $83, after swinging between roughly $70.70 and $84.19 on the day and posting unusually heavy volume (about 70.6 million shares). That move didn’t happen in a vacuum. Over the past 10 days, CoreWeave stock has been whipsawed by a familiar mix of catalysts for “AI infrastructure” names: analyst coverage shifts, government partnerships, construction-and-capacity headlines, and investor unease about the sector’s debt-funded buildout. Here’s what matters for CRWV right now,
20 December 2025
·····
1 … 3 4 5 6 7 … 26

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop